Aerie Pharmaceuticals Inc

DEUTSCHE BANK AG\

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

740,882

Value ($000)

11,210

Weight

0.0%

2013 Q4 - 2022 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	11,210	0.0%	740,882	9/30/2022
2022 Q2	8/11/2022	7,526	0.0%	1,003,443	6/30/2022
2022 Q1	5/13/2022	2,582	0.0%	283,699	3/31/2022
2021 Q4	2/16/2022	2,147	0.0%	305,784	12/31/2021
2021 Q3	11/4/2021	6,491	0.0%	569,448	9/30/2021
2021 Q2	8/11/2021	10,338	0.0%	645,688	6/30/2021
2021 Q1	5/13/2021	12,553	0.0%	702,413	3/31/2021
2020 Q4	2/16/2021	4,888	0.0%	361,813	12/31/2020
2020 Q3	11/12/2020	3,193	0.0%	271,292	9/30/2020
2020 Q2	8/13/2020	1,688	0.0%	114,395	6/30/2020
2020 Q1	5/14/2020	369	0.0%	27,359	3/31/2020
2019 Q4	2/14/2020	546	0.0%	22,659	12/31/2019
2018 Q3	12/21/2021	5,989	—	97,301	9/30/2018
2018 Q2	4/21/2020	13,589	—	201,172	6/30/2018
2014 Q1	5/15/2014	146	0.0%	6,913	3/31/2014
2013 Q4	2/24/2014	556	0.0%	31,046	12/31/2013